Search
Now showing items 11-20 of 25
Impact of Genetic Features on Treatment Decisions in AML
Döhner, Hartmut; Gaidzik, Verena I. (2011)
Wissenschaftlicher Artikel
Bendamustine Combined With Rituximab in Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia: A Multicenter Phase II Trial of the German Chronic Lymphocytic Leukemia Study Group
Fischer, Kirsten et al. (2011)
Wissenschaftlicher Artikel
Molecular Characterization of AML with ins(21;8)(q22;q22q22) Reveals Similarity to t(8;21) AML
Ruecker, Frank G. et al. (2011)
Wissenschaftlicher Artikel
Chronic Lymphocytic Leukemia: Pathophysiology, Diagnosis and Manifestations, and Prognostic Markers
Zenz, Thorsten; Döhner, Hartmut; Stilgenbauer, Stephan (2011)
Teil eines Buches
Prognostic impact, concurrent genetic mutations, and gene expression features of AML with CEBPA mutations in a cohort of 1182 cytogenetically normal AML patients: further evidence for CEBPA double mutant AML as a distinctive disease entity
Taskesen, Erdogan et al. (2011)
Wissenschaftlicher Artikel
Allogeneic stem cell transplant to eliminate germline mutations in the gene for CCAAT-enhancer-binding protein alpha from hematopoietic cells in a family with AML
Stelljes, M. et al. (2011)
Wissenschaftlicher Artikel
DNMT3A mutations in myeloproliferative neoplasms
Stegelmann, F. et al. (2011)
Wissenschaftlicher Artikel
RUNX1 Mutations in Acute Myeloid Leukemia: Results From a Comprehensive Genetic and Clinical Analysis From the AML Study Group
Gaidzik, Verena I. et al. (2011)
Wissenschaftlicher Artikel
The clathrin-binding domain of CALM and the OM-LZ domain of AF10 are sufficient to induce acute myeloid leukemia in mice
Deshpande, A. J. et al. (2011)
Wissenschaftlicher Artikel
Prognostic Importance of Histone Methyltransferase MLL5 Expression in Acute Myeloid Leukemia
Damm, Frederik et al. (2011)
Wissenschaftlicher Artikel